Brasil Pharma (BSP:BPHA3) Long-Term Debt : R$59.92 Mil (As of Mar. 2019)

View and export this data going back to 2011. Start your Free Trial

What is Brasil Pharma Long-Term Debt?

Brasil Pharma's Long-Term Debt for the quarter that ended in Mar. 2019 was R$59.92 Mil.

Brasil Pharma's quarterly Long-Term Debt increased from Sep. 2018 (R$0.00 Mil) to Dec. 2018 (R$48.83 Mil) and increased from Dec. 2018 (R$48.83 Mil) to Mar. 2019 (R$59.92 Mil).

Brasil Pharma's annual Long-Term Debt declined from Dec. 2016 (R$8.37 Mil) to Dec. 2017 (R$0.00 Mil) but then increased from Dec. 2017 (R$0.00 Mil) to Dec. 2018 (R$48.83 Mil).

Brasil Pharma Long-Term Debt Historical Data

The historical data trend for Brasil Pharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brasil Pharma Long-Term Debt Chart

Brasil Pharma Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Long-Term Debt

Get a 7-Day Free Trial

104.59

18.46

8.37

48.83

Brasil Pharma Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	48.83	59.92

Brasil Pharma (BSP:BPHA3) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Brasil Pharma Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Brasil Pharma's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Brasil Pharma (BSP:BPHA3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brasil Pharma SA (BSP:BPHA3) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenida Presidente Juscelino Kubitschek, 1,830, 3rd floor, Itaim Bibi, Sao Paulo, SP, BRA, 04543-900

Website

http://www.brasilpharma.com.br

Brasil Pharma SA is a Brazil-based company primarily engaged in the pharmaceutical retail sector. The company operates in the retail sale of medicines, perfumes, cosmetics, skincare and beauty products and toiletries. The operating segments of the company are Retail sector and Service sector, of which majority of the revenue is generated from the Retail segment. The group has its presence in all the regions of Brazil through its own stores and a franchise network. The owned stores of the company are operated under the Big Ben, Guararapes, District Pharmacy Rosary, Sant'Ana and Mais Economica brands. The company's franchises operate under the Farmais brand.

Brasil Pharma (BSP:BPHA3) Headlines

No Headlines